Wedbush Securities Inc Pds Biotechnology Corp Put Options Transaction History
Wedbush Securities Inc
- $3.06 Billion
- Q3 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding PDSB
# of Institutions
59Shares Held
7.76MCall Options Held
280KPut Options Held
0-
Armistice Capital, LLC New York, NY2.24MShares$1.9 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.9MShares$1.62 Million0.0% of portfolio
-
Black Rock Inc. New York, NY487KShares$413,9210.0% of portfolio
-
Geode Capital Management, LLC Boston, MA482KShares$409,6990.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il386KShares$328,4650.0% of portfolio
About PDS Biotechnology Corp
- Ticker PDSB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,458,700
- Market Cap $24.2M
- Description
- PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...